Myriad Genetics receives FDA approval for MyChoice CDx as Zejula companion test

March 17, 2026 4:05 PM

Myriad Genetics Inc. (NASDAQ: MYGN) announced that the U.S. Food and Drug Administration has approved its MyChoice CDx Test as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found